| Elucidating compound mechanism of action by network perturbation analysis JH Woo, Y Shimoni, WS Yang, P Subramaniam, A Iyer, P Nicoletti, ... Cell 162 (2), 441-451, 2015 | 360 | 2015 |
| A community computational challenge to predict the activity of pairs of compounds M Bansal, J Yang, C Karan, MP Menden, JC Costello, H Tang, G Xiao, ... Nature biotechnology 32 (12), 1213-1222, 2014 | 331 | 2014 |
| A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors MJ Alvarez, PS Subramaniam, LH Tang, A Grunn, M Aburi, G Rieckhof, ... Nature genetics 50 (7), 979-989, 2018 | 205 | 2018 |
| Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies C Deng, MR Lipstein, L Scotto, XO Jirau Serrano, MA Mangone, S Li, ... Blood, The Journal of the American Society of Hematology 129 (1), 88-99, 2017 | 125 | 2017 |
| Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials B Gold, M Pingle, SJ Brickner, N Shah, J Roberts, M Rundell, WC Bracken, ... Proceedings of the National Academy of Sciences 109 (40), 16004-16011, 2012 | 117 | 2012 |
| PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens EC Bush, F Ray, MJ Alvarez, R Realubit, H Li, C Karan, A Califano, ... Nature communications 8 (1), 105, 2017 | 108 | 2017 |
| Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy M Porotto, G Orefice, CC Yokoyama, BA Mungall, R Realubit, ML Sganga, ... Journal of virology 83 (10), 5148-5155, 2009 | 102 | 2009 |
| Preclinical pharmacologic evaluation of pralatrexate and romidepsin confirms potent synergy of the combination in a murine model of human T-cell lymphoma S Jain, X Jirau-Serrano, KM Zullo, L Scotto, CF Palermo, SA Sastra, ... Clinical Cancer Research 21 (9), 2096-2106, 2015 | 63 | 2015 |
| Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma AM Sonabend, AS Carminucci, B Amendolara, M Bansal, R Leung, L Lei, ... Neuro-oncology 16 (9), 1210-1219, 2014 | 44 | 2014 |
| Inhibition of NF-κB–Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma G Ambrosini, C Do, B Tycko, RB Realubit, C Karan, E Musi, RD Carvajal, ... Cancer research 79 (9), 2415-2425, 2019 | 41 | 2019 |
| TSH receptor signaling abrogation by a novel small molecule R Latif, RB Realubit, C Karan, M Mezei, TF Davies Frontiers in endocrinology 7, 130, 2016 | 41 | 2016 |
| Systematic, network-based characterization of therapeutic target inhibitors Y Shen, MJ Alvarez, B Bisikirska, A Lachmann, R Realubit, S Pampou, ... PLoS computational biology 13 (10), e1005599, 2017 | 27 | 2017 |
| Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators A Obradovic, C Ager, M Turunen, T Nirschl, M Khosravi-Maharlooei, ... Cancer Cell 41 (5), 933-949. e11, 2023 | 25 | 2023 |
| Bioactive compound screen for pharmacological enhancers of apolipoprotein E in primary human astrocytes GM Finan, R Realubit, S Chung, D Lütjohann, N Wang, JR Cirrito, ... Cell chemical biology 23 (12), 1526-1538, 2016 | 25 | 2016 |
| OncoLoop: A network-based precision cancer medicine framework A Vasciaveo, JM Arriaga, FN De Almeida, M Zou, EF Douglass Jr, ... Cancer discovery 13 (2), 386-409, 2023 | 24 | 2023 |
| The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies JEL Diaz, ME Ahsen, T Schaffter, X Chen, RB Realubit, C Karan, ... Elife 9, e52707, 2020 | 24 | 2020 |
| The host cell virocheckpoint: identification and pharmacologic targeting of novel mechanistic determinants of coronavirus-mediated hijacked cell states P Laise, G Bosker, X Sun, Y Shen, EF Douglass, C Karan, RB Realubit, ... BioRxiv, 2020 | 15 | 2020 |
| Reply to ‘H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines’ MJ Alvarez, P Yan, ML Alpaugh, M Bowden, E Sicinska, CW Zhou, ... Nature genetics 51 (10), 1427-1428, 2019 | 15 | 2019 |
| A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies PS Mundi, FS Dela Cruz, A Grunn, D Diolaiti, A Mauguen, AR Rainey, ... Cancer discovery 13 (6), 1386-1407, 2023 | 14 | 2023 |
| A novel, rapid method to compare the therapeutic windows of oral anticoagulants using the Hill coefficient JB Chang, KM Quinnies, R Realubit, C Karan, JH Rand, NP Tatonetti Scientific Reports 6 (1), 29387, 2016 | 14 | 2016 |
